Skip to main content
ICUIICU Medical, Inc.Sell4.5·$154.42-1.34%
ICUI · Why this verdict

Why ICU Medical (ICUI) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.5/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

The company has delivered a perfect four-quarter earnings beat streak with an exceptional average positive surprise and extraordinary free cash flow conversion, but revenue is declining and the current price offers thin reward against meaningful downside — keeping conviction limited despite the encouraging earnings track record.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

The company has beaten consensus earnings estimates in each of the last four quarters, with an average positive surprise of approximately 27% — a pattern of consistent and material outperformance suggesting the business is delivering significantly above market expectations.

Stable
Catalyst breakdown
Expectation
The next quarterly earnings report produces a positive surprise, extending the perfect streak to five consecutive beats.

CounterThe two most recent quarters produced surprises of approximately 12-13% — materially smaller than the two prior quarters where surprises exceeded 40% — suggesting the magnitude of outperformance may be compressing as estimates adjust upward.

Revenue has declined approximately 12%, with the growth score at zero — indicating that despite the strong earnings beat streak, the top-line trajectory is heading in the wrong direction and raises questions about the sustainability of earnings growth driven purely by cost discipline.

Stable
Growth breakdown
Expectation
Revenue growth turns positive and exceeds 3% year-over-year for 2 consecutive quarters, reversing the declining trend.

CounterA company can sustain or grow earnings even with declining revenue through margin improvement or mix shift, and the strong earnings beat record suggests management is executing effectively despite the revenue headwind.

The company converts approximately 835% of reported net income into free cash flow — far above 100% — suggesting accounting earnings significantly understate the cash being generated by the business and providing meaningful financial flexibility.

Stable
Quality breakdown
Expectation
Free cash flow conversion remains above 300% of net income over the next four quarters, confirming the exceptional cash generation is sustained rather than a one-time effect.

CounterA FCF/NI ratio this high is unusual and may reflect very low net income from large non-cash charges rather than organically superior cash generation — if those charges normalize, the ratio could revert dramatically.

With only 4.6% upside to the price target against approximately 6.7% potential downside, the risk/reward ratio of 0.69 is well below the threshold at which the setup becomes asymmetric — making the current entry unattractive despite strong earnings execution.

Stable
Price targets
Expectation
If this pillar is wrong, a price pullback to below $135 expands upside to the $150.39 target to more than 11%, creating a materially improved entry point.

CounterAnalysts see approximately 20% upside from consensus estimates, and a cluster of recent analyst attention has emerged — if analyst upgrades materialize, the price target may be revised higher, expanding the geometric upside without requiring a pullback.

Per-dimension breakdown

Value

5.9/10data confidence 100%
ComponentSub-score
P/E0.8
P/S9.1
EV/EBITDA2.4
Fwd P/E7.4
PEG10.0
Analyst target4.0
  • Forward P/E: 16.8x
  • PEG: 0.09

Quality

4.5/10data confidence 100%
ComponentSub-score
ROE0.8
ROA1.1
Gross margin3.6
Op margin2.3
Net margin1.1
Current ratio8.0
FCF quality10.0
Moat4.6
Piotroski F8.9
  • Excellent cash conversion: 835% FCF/NI
  • No competitive moat
  • Strong Piotroski F-Score: 8/9

Growth

0.0/10data confidence 33%
ComponentSub-score
Rev growth0.0
  • Declining revenue: -12%

Momentum

5.2/10data confidence 100%
ComponentSub-score
RSI5.0
MACD10.0
OBV1.0
MA position9.0
Volume0.9
  • Volume distribution (falling OBV)
  • Above 200-day MA

Sentiment

6.4/10data confidence 100%
ComponentSub-score
Analyst rating6.8
Price target6.7
erm sentiment5.5
  • Light analyst coverage (8.0) — signal dampened

Insider

5.9/10data confidence 100%
ComponentSub-score
materiality4.5
insider conviction2.0
holder change10.0
notable moves7.0
  • Modest insider selling — $882,242 (0.023% of mkt cap)
  • Institutions accumulating

Peer rank

2.8/10data confidence 80%
ComponentSub-score
value rank3.8
quality rank4.6
growth rank0.0

Technical

4.7/10data confidence 100%
ComponentSub-score
bollinger2.3
support resistance2.9
52w position9.0

Risk (lower is worse)

5.4/10data confidence 100%
ComponentSub-score
short interest5.8
days to cover4.5
volatility3.7
put call5.3
implied vol3.2
max pain risk5.0
beta8.4
debt equity7.2
  • High IV: 61%
  • Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

7.5/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg10.0
  • Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:5.2>=4.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:27d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.2=NEGATIVE
Warning (1)
  • MOMENTUM:5.2<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
-0.22
Upside
-2.8%
Downside
12.5%
Sizing output
AVOID

SetupMomentum Cont Trend continuation, RSI 65, MACD bullish

EdgeCatalyst-Driven Earnings in 27d with 4/4 beat streak

SuitabilityAggressive MCap $3.9B<$5B

Investment implication

The F-path SELL output reflects an overall score of 4.5 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Catalyst at 7.5) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.2=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.22 — supplementary context, not the trigger for this path.

The strongest dimensions are Catalyst at 7.5, Sentiment at 6.4, and Value at 5.9; the weakest are Growth at 0.0, Peer rank at 2.8, and Quality at 4.5. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.22 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Perfect Earnings Beat Streak

    Trip ifEPS surprise falls below 0% in any single quarter in the next 4 quarterly reports, breaking the perfect beat streak.

  • P2Declining Revenue Structural Headwind

    Trip ifRevenue growth turns positive and exceeds 3% year-over-year for 2 consecutive quarters, reversing the declining trend.

  • P3Exceptional Free Cash Flow Conversion

    Trip ifFCF/NI ratio falls below 300% for 2 consecutive quarters, indicating a material deterioration in the exceptional cash conversion profile.

  • P4Thin Reward Against Downside

    Trip ifStock price falls below $135, increasing upside to the $150.39 price target to more than 11% and creating a favorable risk/reward entry point.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks ICUI Why this verdict